ArticleJournal of clinical immunology2012

A benzamide-linked small molecule NDMC101 inhibits NFATc1 and NF-κB activity: a potential osteoclastogenesis inhibitor for experimental arthritis.

Chia-Pi Cheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.